These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 34037220)

  • 41. Marital Status and Long-Term Outcomes in Mild Heart Failure Patients With an Implantable Cardioverter Defibrillator or Cardiac Resynchronization Therapy With Defibrillator.
    Goldenberg M; Aktas MK; Younis A; Zareba W; McNitt S; Kutyifa V
    Am J Cardiol; 2020 Apr; 125(8):1180-1186. PubMed ID: 32088000
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Patients upgraded to cardiac resynchronization therapy due to pacing-induced cardiomyopathy are at low risk of life-threatening ventricular arrhythmias: a long-term cause-of-death analysis.
    Barra S; Duehmke R; Providencia R; Marijon E; Boveda S; Virdee M; Heck P; Fynn S; Begley D; Grace A; Agarwal S
    Europace; 2018 Jan; 20(1):89-96. PubMed ID: 28031276
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Atrial fibrillation in cardiac resynchronization therapy with a defibrillator: a risk factor for mortality, appropriate and inappropriate shocks.
    van Boven N; Theuns D; Bogaard K; Ruiter J; Kimman G; Berman L; VAN DER Ploeg T; Kardys I; Umans V
    J Cardiovasc Electrophysiol; 2013 Oct; 24(10):1116-22. PubMed ID: 23889733
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Appropriate implantable cardioverter-defibrillator interventions in cardiac resynchronization therapy-defibrillator (CRT-D) patients undergoing device replacement: time to downgrade from CRT-D to CRT-pacemaker? Insights from real-world clinical practice in the DECODE CRT-D analysis.
    Narducci ML; Biffi M; Ammendola E; Vado A; Campana A; Potenza DR; Iori M; Zanon F; Zacà V; Zoni Berisso M; Bertini M; Lissoni F; Bandini A; Malacrida M; Crea F
    Europace; 2018 Sep; 20(9):1475-1483. PubMed ID: 29186401
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The European Cardiac Resynchronization Therapy Survey: comparison of outcomes between de novo cardiac resynchronization therapy implantations and upgrades.
    Bogale N; Witte K; Priori S; Cleland J; Auricchio A; Gadler F; Gitt A; Limbourg T; Linde C; Dickstein K;
    Eur J Heart Fail; 2011 Sep; 13(9):974-83. PubMed ID: 21771823
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Risk factors and the effect of cardiac resynchronization therapy on cardiac and non-cardiac mortality in MADIT-CRT.
    Perkiomaki JS; Ruwald AC; Kutyifa V; Ruwald MH; Mcnitt S; Polonsky B; Goldstein RE; Haigney MC; Krone RJ; Zareba W; Moss AJ;
    Europace; 2015 Dec; 17(12):1816-22. PubMed ID: 26071234
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Impact of the right ventricular lead position on clinical outcome and on the incidence of ventricular tachyarrhythmias in patients with CRT-D.
    Kutyifa V; Bloch Thomsen PE; Huang DT; Rosero S; Tompkins C; Jons C; McNitt S; Polonsky B; Shah A; Merkely B; Solomon SD; Moss AJ; Zareba W; Klein HU
    Heart Rhythm; 2013 Dec; 10(12):1770-7. PubMed ID: 23973954
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Super-response to cardiac resynchronization therapy reduces appropriate implantable cardioverter defibrillator therapy.
    Killu AM; Mazo A; Grupper A; Madhavan M; Webster T; Brooke KL; Hodge DO; Asirvatham SJ; Friedman PA; Glikson M; Cha YM
    Europace; 2018 Aug; 20(8):1303-1311. PubMed ID: 29016821
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Long-term outcomes of cardiac resynchronization therapy by left ventricular ejection fraction.
    Kutyifa V; Vermilye K; Solomon SD; McNitt S; Moss AJ; Daimee UA
    Eur J Heart Fail; 2019 Mar; 21(3):360-369. PubMed ID: 30592353
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Association between implantable cardioverter-defibrillator therapy and different lead positions in patients with cardiac resynchronization therapy.
    Kronborg MB; Johansen JB; Haarbo J; Riahi S; Philbert BT; Jørgensen OD; Nielsen JC
    Europace; 2018 Sep; 20(9):e133-e139. PubMed ID: 29036292
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Upgrades from a previous device compared to de novo cardiac resynchronization therapy in the European Society of Cardiology CRT Survey II.
    Linde CM; Normand C; Bogale N; Auricchio A; Sterlinski M; Marinskis G; Sticherling C; Bulava A; Pérez ÓC; Maass AH; Witte KK; Rekvava R; Abdelali S; Dickstein K
    Eur J Heart Fail; 2018 Oct; 20(10):1457-1468. PubMed ID: 29806208
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Comparative Effectiveness of Cardiac Resynchronization Therapy Among Patients With Heart Failure and Atrial Fibrillation: Findings From the National Cardiovascular Data Registry's Implantable Cardioverter-Defibrillator Registry.
    Khazanie P; Greiner MA; Al-Khatib SM; Piccini JP; Turakhia MP; Varosy PD; Masoudi FA; Curtis LH; Hernandez AF;
    Circ Heart Fail; 2016 Jun; 9(6):. PubMed ID: 27296396
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Cardiac resynchronization therapy-defibrillator improves long-term survival compared with cardiac resynchronization therapy-pacemaker in patients with a class IA indication for cardiac resynchronization therapy: data from the Contak Italian Registry.
    Morani G; Gasparini M; Zanon F; Casali E; Spotti A; Reggiani A; Bertaglia E; Solimene F; Molon G; Accogli M; Tommasi C; Paoletti Perini A; Ciardiello C; Padeletti L
    Europace; 2013 Sep; 15(9):1273-9. PubMed ID: 23439866
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The prognostic benefit of cardiac resynchronization therapy is greater in concordant vs. discordant left bundle branch block in the Multicenter Automatic Defibrillator Implantation Trial-Cardiac Resynchronization Therapy (MADIT-CRT).
    Padeletti L; Aimo A; Vishenvsky B; Schwartz A; McNitt S; Wang PJ; Moss AJ; Emdin M; Zareba W
    Europace; 2018 May; 20(5):794-800. PubMed ID: 28398490
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Effectiveness of Cardiac Resynchronization Therapy by QRS Morphology in the Multicenter Automatic Defibrillator Implantation Trial-Cardiac Resynchronization Therapy (MADIT-CRT).
    Zareba W; Klein H; Cygankiewicz I; Hall WJ; McNitt S; Brown M; Cannom D; Daubert JP; Eldar M; Gold MR; Goldberger JJ; Goldenberg I; Lichstein E; Pitschner H; Rashtian M; Solomon S; Viskin S; Wang P; Moss AJ;
    Circulation; 2011 Mar; 123(10):1061-72. PubMed ID: 21357819
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Implantable cardioverter-defibrillator patients who are upgraded and respond to cardiac resynchronization therapy have less ventricular arrhythmias compared with nonresponders.
    Thijssen J; Borleffs CJ; Delgado V; van Rees JB; Mooyaart EA; van Bommel RJ; van Erven L; Boersma E; Bax JJ; Schalij MJ
    J Am Coll Cardiol; 2011 Nov; 58(22):2282-9. PubMed ID: 22093504
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Implantable defibrillators improve survival in patients with mildly symptomatic heart failure receiving cardiac resynchronization therapy: analysis of the long-term follow-up of remodeling in systolic left ventricular dysfunction (REVERSE).
    Gold MR; Daubert JC; Abraham WT; Hassager C; Dinerman JL; Hudnall JH; Cerkvenik J; Linde C
    Circ Arrhythm Electrophysiol; 2013 Dec; 6(6):1163-8. PubMed ID: 24125796
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Left Ventricular Lead Location and Long-Term Outcomes in Cardiac Resynchronization Therapy Patients.
    Kutyifa V; Kosztin A; Klein HU; Biton Y; Nagy VK; Solomon SD; McNitt S; Zareba W; Goldenberg I; Roka A; Moss AJ; Merkely B; Singh JP
    JACC Clin Electrophysiol; 2018 Nov; 4(11):1410-1420. PubMed ID: 30466845
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Utility of Frailty Assessment for Elderly Patients Undergoing Cardiac Resynchronization Therapy.
    Kubala M; Guédon-Moreau L; Anselme F; Klug D; Bertaina G; Traullé S; Buiciuc O; Savouré A; Diouf M; Hermida JS
    JACC Clin Electrophysiol; 2017 Dec; 3(13):1523-1533. PubMed ID: 29759834
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Reduction in long-term mortality using remote device monitoring in a large real-world population of patients with implantable defibrillators.
    Kolk MZH; Narayan SM; Clopton P; Wilde AAM; Knops RE; Tjong FVY
    Europace; 2023 Mar; 25(3):969-977. PubMed ID: 36636951
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.